Comparison of CD157 surface expression by flow cytometry in paired diagnosis and relapse AML samples showed it was stably expressed [73], suggesting that it may be a helpful marker for minimal residual disease detection. The gene discussed is BST1; the disease is acute myeloid leukemia.